Shalom Hirschman

Dr. Shalom Z.
Hirschman, MD, is a Chief Scientific Officer & Medical Director at EOM Pharmaceuticals Holdings, Inc., a Chief Scientific Officer & Medical Director at EOM Pharmaceuticals, Inc., a Member at American Association for the Advancement of Science, a Member at American Federation For Clinical Research, a Member at American Medical Association, a Member at American Society for Microbiology, a Member at Harvey Society and a Member at Society for Experimental Biology & Medicine.
Dr. Hirschman was previously employed as an Independent Director by Greenland Mines Ltd., a Chief Scientific Officer by ImmunoCellular Therapeutics Ltd., a Chairman, Chief Executive & Accounting Officer by QuantRx Biomedical Corp., a Director-Infectious Diseases Division & Professor by Mount Sinai School of Medicine, a President, Chief Executive & Scientific Officer by Advanced Viral Research Corp., a Member by American College of Clinical Pharmacology, a Member by American College of Physicians, a Member by American Society for Clinical Investigation, a Member by Association of American Physicians, a Member by Infectious Diseases Society of America, a Chairman by New York Academy of Sciences, a Member by The Biophysical Society, a Vice Chairman by The Mount Sinai Hospital, a Member by The Royal Society of Tropical Medicine & Hygiene, a Senior Vice President by Touro College, a Founder by Touro College & University System, and a Founder by Xtramedics, Inc. He received his doctorate degree from Albert Einstein College of Medicine, Inc..